Docking and chemoinformatic screens for new ligands and targets.

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Current Opinion in Biotechnology

• Publication date

  2009-08-01

• Fields of study

  Biology, Medicine, Chemistry, Computer Science

• Identifiers
  DOI 10.1016/j.copbio.2009.08.003PMID 19733475PMCID PMC2766606
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Quantifying Biogenic Bias in Screening Libraries

  2009cited by this paper
• Drug Discovery Using Chemical Systems Biology: Repositioning the Safe Medicine Comtan to Treat Multi-Drug and Extensively Drug Resistant Tuberculosis

  2009cited by this paper
• Community-wide assessment of GPCR structure modelling and ligand docking: GPCR Dock 2008

  2009cited by this paper
• Identifying conformational changes of the β2 adrenoceptor that enable accurate prediction of ligand/receptor interactions and screening for GPCR modulators

  2009cited by this paper
• Functional annotation and three-dimensional structure of Dr0930 from Deinococcus radiodurans, a close relative of phosphotriesterase in the amidohydrolase superfamily.

  2009cited by this paper
• Merging chemical and biological space: Structural mapping of enzyme binding pocket space

  2009cited by this paper
• Mapping adverse drug reactions in chemical space.

  2009cited by this paper
• Structure-based discovery of β2-adrenergic receptor ligands

  2009cited by this paper
• Virtual Screening and Biological Characterization of Novel Histone Arginine Methyltransferase PRMT1 Inhibitors

  2009cited by this paper
• Discovery of novel chemotypes to a G-protein-coupled receptor through ligand-steered homology modeling and structure-based virtual screening.

  2008cited by this paper
• A virtual screen for diverse ligands: discovery of selective G protein-coupled receptor antagonists.

  2008cited by this paper
• Novel inhibitors of anthrax edema factor.

  2008cited by this paper
• Network pharmacology: the next paradigm in drug discovery.

  2008cited by this paper
• Selective structure-based virtual screening for full and partial agonists of the beta2 adrenergic receptor.

  2008cited by this paper
• A high-throughput screening method for small-molecule pharmacologic chaperones of misfolded rhodopsin.

  2008cited by this paper
• Structure of a β1-adrenergic G-protein-coupled receptor

  2008cited by this paper
• Data completeness—the Achilles heel of drug-target networks

  2008cited by this paper
• Structure‐Based Discovery and Experimental Verification of Novel AI‐2 Quorum Sensing Inhibitors against Vibrio harveyi

  2008cited by this paper
• Structure‐based tailoring of compound libraries for high‐throughput screening: Discovery of novel EphB4 kinase inhibitors

  2008cited by this paper
• The 2.6 Angstrom Crystal Structure of a Human A2A Adenosine Receptor Bound to an Antagonist

  2008cited by this paper
• Use of the X-ray structure of the beta2-adrenergic receptor for drug discovery. Part 2: Identification of active compounds.

  2008cited by this paper
• Discovery of novel agonists and antagonists of the free fatty acid receptor 1 (FFAR1) using virtual screening.

  2008cited by this paper
• Identification of small molecular weight inhibitors of Src homology 2 domain-containing tyrosine phosphatase 2 (SHP-2) via in silico database screening combined with experimental assay.

  2008cited by this paper
• Discovery of novel human histamine H4 receptor ligands by large-scale structure-based virtual screening.

  2008cited by this paper
• Molecular docking for substrate identification: the short-chain dehydrogenases/reductases.

  2008cited by this paper
• Receptor-Based Virtual Ligand Screening for the Identification of Novel CDC25 Phosphatase Inhibitors

  2008cited by this paper
• Comprehensive mechanistic analysis of hits from high-throughput and docking screens against beta-lactamase.

  2008cited by this paper
• Massively parallel screening of the receptorome.

  2008cited by this paper
• Drug Target Identification Using Side-Effect Similarity

  2008cited by this paper
• Docking study yields four novel inhibitors of the protooncogene Pim-1 kinase.

  2008cited by this paper
• Structure-based activity prediction for an enzyme of unknown function

  2007influential reference
• Generation of a homology model of the human histamine H3 receptor for ligand docking and pharmacophore-based screening

  2007cited by this paper
• High-resolution crystal structure of an engineered human beta2-adrenergic G protein-coupled receptor.

  2007cited by this paper
• Discovery of Novel DNA Gyrase Inhibitors by High-Throughput Virtual Screening

  2007cited by this paper
• Discovery of a Highly Active Ligand of Human Pregnane X Receptor: A Case Study from Pharmacophore Modeling and Virtual Screening to “In Vivo” Biological Activity

  2007influential reference
• In Silico Chemical Library Screening and Experimental Validation of a Novel 9-Aminoacridine Based Lead-Inhibitor of Human S-Adenosylmethionine Decarboxylase

  2007cited by this paper
• A high-throughput screen for aggregation-based inhibition in a large compound library.

  2007cited by this paper
• Structural and thermodynamic study on aldose reductase: nitro-substituted inhibitors with strong enthalpic binding contribution.

  2007cited by this paper
• GPCR Engineering Yields High-Resolution Structural Insights into β2-Adrenergic Receptor Function

  2007cited by this paper
• Identification of some novel AHAS inhibitors via molecular docking and virtual screening approach.

  2007cited by this paper
• Crystal structure of calf spleen purine nucleoside phosphorylase complexed to a novel purine analogue

  2007cited by this paper
• Drug—target network

  2007cited by this paper
• Novel PPAR‐gamma Agonists Identified from a Natural Product Library: A Virtual Screening, Induced‐Fit Docking and Biological Assay Study

  2007cited by this paper
• High-Resolution Crystal Structure of an Engineered Human β2-Adrenergic G Protein–Coupled Receptor

  2007cited by this paper
• Relating protein pharmacology by ligand chemistry

  2007cited by this paper
• Prediction of protein-ligand interactions. Docking and scoring: successes and gaps.

  2006cited by this paper
• Virtual and biomolecular screening converge on a selective agonist for GPR30

  2006cited by this paper
• Global mapping of pharmacological space

  2006cited by this paper
• How many drug targets are there?

  2006cited by this paper
• Comparative virtual and experimental high-throughput screening for glycogen synthase kinase-3beta inhibitors.

  2005cited by this paper
• Integration of Virtual Screening with High-Throughput Flow Cytometry to Identify Novel Small Molecule Formylpeptide Receptor Antagonistss⃞

  2005cited by this paper
• Performance of 3D-database molecular docking studies into homology models.

  2004cited by this paper
• Magic shotguns versus magic bullets: selectively non-selective drugs for mood disorders and schizophrenia

  2004cited by this paper
• Crystal Structure of Rhodopsin: A G‐Protein‐Coupled Receptor

  2002cited by this paper
• Molecular docking and high-throughput screening for novel inhibitors of protein tyrosine phosphatase-1B.

  2002cited by this paper
• Inhibitors of dihydrodipicolinate reductase, a key enzyme of the diaminopimelate pathway of Mycobacterium tuberculosis.

  2001cited by this paper
• Crystal structure of rhodopsin: A G protein-coupled receptor.

  2000cited by this paper
• Drug design by the method of receptor fit.

  1984cited by this paper

• Integrated In Vitro and In Silico Evaluation of the Antimicrobial and Cytotoxic Potential of Calotropis procera Leaf Ethanolic Extract: From GC-MS Profiling to Molecular Docking and Dynamics

  2025cites this paper
• Structural elucidation of Cocculus hirsutus trypsin inhibitor and insights into its mechanism of action

  2025cites this paper
• Isolation of compound and molecular docking studies of Wedelia calendulacea extract fractions against dengue vector, Aedes aegypti

  2025cites this paper
• Enhancing the Reliability of Integrated Consensus Strategies to Boost Docking‐Based Screening Campaigns Using Publicly Available Docking Programs

  2025cites this paper
• Tryptoline Stereoprobe Elaboration Identifies Inhibitors of the GRPEL1-HSPA9 Chaperone Complex

  2025cites this paper
• Unlocking Benzosampangine’s Potential: A Computational Approach to Investigating, Its Role as a PD-L1 Inhibitor in Tumor Immune Evasion via Molecular Docking, Dynamic Simulation, and ADMET Profiling

  2024cites this paper
• Synthesis, Spectroscopic Analysis, Molecular Docking and DFT Study of Novel 1,2,3-Triazole Derivatives Incorporating paramethoxythymol and Salicylaldehyde Moieties

  2024cites this paper
• Exploring the Fatty Acid Binding Pocket in the SARS-CoV-2 Spike Protein - Confirmed and Potential Ligands

  2023cites this paper
• How accurately can one predict drug binding modes using AlphaFold models?

  2023cites this paper
• Structure-based discovery of novel cruzain inhibitors with distinct trypanocidal activity profiles.

  2023cites this paper
• Allosteric modulators of solute carrier function: a theoretical framework

  2023cites this paper
• Elucidating disease-associated mechanisms triggered by pollutants via the epigenetic landscape using large-scale ChIP-Seq data

  2023cites this paper
• Structure-based Discovery of Conformationally Selective Inhibitors of the Serotonin Transporter

  2022cites this paper
• Elicitation of apigenin in green leafy vegetable plants and its molecular docking evaluation for effective anticancer applications

  2022cites this paper
• Epigenetic landscape of drug responses revealed through large-scale ChIP-seq data analyses

  2022cites this paper
• In silico molecular docking study of plant-based compounds from medicinal plant Lantana camara L. against Aedes aegypti L. protein

  2022cites this paper
• Structural similarities between SARS-CoV2 3CLpro and other viral proteases suggest potential lead molecules for developing broad spectrum antivirals

  2022cites this paper
• Repurposing of Drugs: Updates and New Perspectives

  2022cites this paper
• A New Combination: Anti Glypican-3 scFv and Diphtheria Toxin with the Best Flexible Linker

  2022cites this paper
• Anti-Inflammatory Properties of Fangji Huangqi Tang: Novel Application Based on Integrated Network Pharmacology Combined with In Vitro Validation

  2022cites this paper
• Artificial intelligence unifies knowledge and actions in drug repositioning.

  2021cites this paper
• Anti-inflammatory Properties of Fangji Huangqi Tang: Discovery Based on Network Pharmacology, Molecular Docking and Arrowsmith Tools

  2021cites this paper
• Structural Consequences of Variation in SARS-CoV-2 B.1.1.7

  2021cites this paper
• Toxicological insights of Spike fragments SARS-CoV-2 by exposure environment: A threat to aquatic health?

  2021cites this paper
• High-Throughput Virtual Screening for a New Class of Antagonist Targeting LasR of Pseudomonas aeruginosa

  2021cites this paper
• Molecular docking studies and virtual drug screening of chemosensitizers

  2021cites this paper
• Can use of hydroxychloroquine and azithromycin as a treatment of COVID-19 affect aquatic wildlife? A study conducted with neotropical tadpole

  2021cites this paper
• Drug Repurposing: An Emerging Tool for Drug Reuse, Recycling and Discovery.

  2021cites this paper
• Molecular Modeling of Histamine Receptors—Recent Advances in Drug Discovery

  2021cites this paper
• Hepatitis C virus drugs that inhibit SARS-CoV-2 papain-like protease synergize with remdesivir to suppress viral replication in cell culture

  2021cites this paper
• An insight into neurotoxic and toxicity of spike fragments SARS-CoV-2 by exposure environment: A threat to aquatic health?

  2021cites this paper
• Selenium overexposure induces insulin resistance: In silico study.

  2020cites this paper
• Hepatitis C Virus Drugs Simeprevir and Grazoprevir Synergize with Remdesivir to Suppress SARS-CoV-2 Replication in Cell Culture

  2020cites this paper
• Discovery and Design of Novel Small Molecule GSK-3 Inhibitors Targeting the Substrate Binding Site

  2020cites this paper
• Biophysics

  2020cites this paper
• Ecotoxicological assessment of pharmaceuticals and personal care products using predictive toxicology approaches

  2020cites this paper
• The future of precision medicine

  2020cites this paper
• New dehydroabietic acid (DHA) derivatives with anticancer activity against HepG2 cancer cell lines as a potential drug targeting EGFR kinase domain. CoMFA study and virtual ligand-based screening

  2020cites this paper
• Structural Similarity of SARS-CoV2 Mpro and HCV NS3/4A Proteases Suggests New Approaches for Identifying Existing Drugs Useful as COVID-19 Therapeutics

  2020cites this paper
• Hepatitis C Virus Drugs Simeprevir And Grazoprevir Synergize with Remdesivir to Suppress SARS-CoV2 Replication

  2020cites this paper
• OBSOLETE: Topical Chemical Space in Relation to Biological Space

  2019cites this paper
• Molecular docking analysis of apigenin and quercetin from ethylacetate fraction of Adansonia digitata with malaria-associated calcium transport protein: An in silico approach

  2019cites this paper
• From biomedicinal to in silico models and back to therapeutics: a review on the advancement of peptidic modeling.

  2019cites this paper
• Small Molecule Drug Design

  2019cites this paper
• A Multi-Label Learning Framework for Drug Repurposing

  2019cites this paper
• Bioinformatics Predictions, Expression, Purification and Structural Analysis of the PE38KDEL-scfv Immunotoxin Against EPHA2 Receptor

  2019cites this paper
• Underground metabolism: network-level perspective and biotechnological potential.

  2018cites this paper
• Translational -omics: Future potential and current challenges in precision medicine.

  2018cites this paper
• Structural insights into serotonin receptor ligands polypharmacology.

  2018cites this paper
• In silico docking and drug design of herbal ligands for anticancer property

  2018cites this paper
• Structure-function studies of β-lactamases

  2018cites this paper
• Drug Repositioning: Concept, Classification, Methodology, and Importance in Rare/Orphans and Neglected Diseases

  2018cites this paper
• High-throughput prediction and analysis of drug-protein interactions in the druggable human proteome

  2018cites this paper
• Accurately accelerating drug design workflow

  2018cites this paper
• Crystal structure of yeast xylose reductase in complex with a novel NADP‐DTT adduct provides insights into substrate recognition and catalysis

  2018cites this paper
• Synthesis and antibacterial evaluation of 13-substituted cycloberberine derivatives as a novel class of anti-MRSA agents.

  2018cites this paper
• Molecular property diagnostic suite for diabetes mellitus (MPDSDM): An integrated web portal for drug discovery and drug repurposing

  2018cites this paper
• Proposing drug fragments for dengue virus NS5 protein

  2018cites this paper
• Binding-Site Compatible Fragment Growing Applied to the Design of β2-Adrenergic Receptor Ligands.

  2018cites this paper
• Design, Docking, Synthesis of Certain Flavonoids and Evaluation of their Angiotensin Converting Enzyme Inhibitory Activity

  2017influential citation
• Chemoinformatische Datenintegration zur Analyse und Vorhersage von Interaktionen von kleinen organischen Molekülen mit deren Biomolekülen (Chemoinformatic data integration to analyse and predict drug-target interactions)

  2017influential citation
• Resource Ligand and Target Discovery by Fragment-Based Screening in Human Cells Graphical

  2017cites this paper
• Computational drug repositioning for rare diseases in the era of precision medicine.

  2017cites this paper
• A comparative molecular docking study of curcumin and methotrexate to dihydrofolate reductase

  2017cites this paper
• Application of computational methods for anticancer drug discovery, design, and optimization

  2017cites this paper
• Drug repositioning for enzyme modulator based on human metabolite-likeness

  2017cites this paper
• WebMolCS: A Web-Based Interface for Visualizing Molecules in Three-Dimensional Chemical Spaces

  2017cites this paper
• DESIGN, SYNTHESIS, INSILICO MOLECULAR DOCKING STUDIES OF SOME NEW ANTI-DIABETIC AMINO ACID ESTERS AS POTENTIAL TARGETS FOR α– AMYLASE

  2017cites this paper
• Modification of S-Adenosyl-l-Homocysteine as Inhibitor of Nonstructural Protein 5 Methyltransferase Dengue Virus Through Molecular Docking and Molecular Dynamics Simulation

  2017cites this paper
• Some Remarks on Prediction of Drug-Target Interaction with Network Models.

  2017cites this paper
• Medicinal Chemistry Profiling of Monocyclic 1,2‐Azaborines

  2017cites this paper
• Fragment Database FDB-17

  2017cites this paper
• Strategies for G-protein coupled receptor deorphanization

  2017cites this paper
• Reliability analysis and optimization of the consensus docking approach for the development of virtual screening studies

  2016cites this paper
• Computational Drug Repositioning by Target Hopping: A Use Case in Chagas Disease.

  2016cites this paper
• Discovery of a Selective Aurora A Kinase Inhibitor by Virtual Screening.

  2016cites this paper
• Regulation of Virulence in Staphylococcus aureus: Molecular Mechanisms and Remaining Puzzles.

  2016cites this paper
• USR-VS: a web server for large-scale prospective virtual screening using ultrafast shape recognition techniques

  2016cites this paper
• Structural Affinity Measurements of Biomolecular Surface for Docking Sites Selection

  2016cites this paper
• Functional and Molecular Characterization of Hedgehog Signalling Regulation

  2016cites this paper
• Molecular Descriptors Selection and Machine Learning Approaches in Protein-Ligand Binding Affinity with Applications to Molecular Docking

  2016cites this paper
• Compound annotation with real time cellular activity profiles to improve drug discovery

  2016cites this paper
• Predicting Unknown Interactions Between Known Drugs and Targets via Matrix Completion

  2016cites this paper
• Evolution of Enzyme Superfamilies: Comprehensive Exploration of Sequence-Function Relationships.

  2016cites this paper
• Application of computational methods for anticancer drug discovery, design, and optimization

  2016cites this paper
• Potential Reuse of Oncology Drugs in the Treatment of Rare Diseases.

  2016cites this paper
• Curcumin binds in silico to anti-cancer drug target enzyme MMP-3 (human stromelysin-1) with affinity comparable to two known inhibitors of the enzyme

  2015cites this paper
• Charting a Path to Success in Virtual Screening

  2015cites this paper
• In silico studies on the role of mutant Y337A to reactivate tabun inhibited mAChE with K048.

  2015cites this paper
• Large-Scale Prediction of Beneficial Drug Combinations Using Drug Efficacy and Target Profiles

  2015cites this paper
• Combining label-free cell phenotypic profiling with computational approaches for novel drug discovery

  2015cites this paper
• Using quantitative systems pharmacology for novel drug discovery

  2015cites this paper
• Other Related Techniques

  2015cites this paper
• Identifying modulators of CXC receptors 3 and 4 with tailored selectivity using multi-target docking.

  2015cites this paper
• Ligand binding and homology modelling of insect odorant‐binding proteins

  2014cites this paper
• Computational Docking as a Tool for the Rational Design of Carbohydrate-Based Drugs

  2014cites this paper
• Biomimetic design of platelet adhesion inhibitors to block integrin α2β1-collagen interactions: II. Inhibitor library, screening, and experimental validation.

  2014cites this paper
• Signal transduction: From the atomic age to the post-genomic era.

  2014cites this paper
• Benchmarking a Wide Range of Chemical Descriptors for Drug‐Target Interaction Prediction Using a Chemogenomic Approach

  2014cites this paper
• Structure-based drug design to overcome drug resistance: challenges and opportunities.

  2014cites this paper